Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AID System with Insulin Lispro in T1DM
NCT03849612Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2019
- Primary completion
- Mar 2019
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Eli Lilly and Company. Primary endpoints: Number of Adverse Events at 5 days and Continuous Glucose Monitor (CGM) Measured Percentage of Time <70 mg/dL at 5 days. Started Feb 2019; status: completed.
Beyond the preview
Go deeper on NCT03849612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03849612.